Thoroughbred Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402K | Sell |
5,147
-13,638
| -73% | -$1.07M | 0.03% | 404 |
|
|
2025
Q1 | $1.36M | Sell |
18,785
-760
| -4% | -$55.1K | 0.09% | 226 |
|
|
2024
Q4 | $1.45M | Buy |
19,545
+465
| +2% | +$34.4K | 0.09% | 211 |
|
|
2024
Q3 | $1.26M | Buy |
19,080
+3,746
| +24% | +$247K | 0.08% | 232 |
|
|
2024
Q2 | $1.42M | Buy |
15,334
+9,556
| +165% | +$882K | 0.09% | 205 |
|
|
2024
Q1 | $552K | Sell |
5,778
-10,074
| -64% | -$962K | 0.05% | 276 |
|
|
2023
Q4 | $1.21M | Sell |
15,852
-107
| -0.7% | -$8.15K | 0.1% | 201 |
|
|
2023
Q3 | $1.11M | Buy |
15,959
+7,962
| +100% | +$551K | 0.11% | 196 |
|
|
2023
Q2 | $754K | Hold |
7,997
| – | – | 0.1% | 199 |
|
|
2023
Q1 | $661K | Sell |
7,997
-384
| -5% | -$31.7K | 0.1% | 207 |
|
|
2022
Q4 | $625K | Sell |
8,381
-655
| -7% | -$48.8K | 0.1% | 208 |
|
|
2022
Q3 | $746K | Sell |
9,036
-255
| -3% | -$21.1K | 0.14% | 159 |
|
|
2022
Q2 | $883K | Hold |
9,291
| – | – | 0.16% | 152 |
|
|
2022
Q1 | $1.09M | Buy |
9,291
+7,062
| +317% | +$831K | 0.18% | 138 |
|
|
2021
Q4 | $288K | Buy |
+2,229
| New | +$288K | 0.06% | 275 |
|
|
2020
Q2 | – | Sell |
-10,002
| Closed | -$629K | – | 230 |
|
|
2020
Q1 | $629K | Buy |
10,002
+2,688
| +37% | +$169K | 0.22% | 122 |
|
|
2019
Q4 | $569K | Buy |
7,314
+2,685
| +58% | +$209K | 0.19% | 136 |
|
|
2019
Q3 | $339K | Buy |
4,629
+285
| +7% | +$20.9K | 0.13% | 170 |
|
|
2019
Q2 | $268K | Buy |
4,344
+435
| +11% | +$26.8K | 0.1% | 161 |
|
|
2019
Q1 | $249K | Buy |
+3,909
| New | +$249K | 0.1% | 195 |
|